Olema Pharmaceuticals, Inc.
OLMA · XNASCIK 1750284fmd_0VQB6PD77MR82G6XZKYQAMFMABManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2019 to Sep 30, 2026, 28 periods
Latest annual · FY2025
Millions- Operating income
- (179)
- Net income
- (162)
- Free cash flow
- (105)
Latest quarter · Q3 FY2026
Millions- Operating income
- (78)
- Net income
- (74)
- Free cash flow
- (48)
Key stats
Open AnalysisCompound annual growth
- Net income, 5 yearsFY2020 to FY2025
- n/m
Olema Pharmaceuticals, Inc. (OLMA) financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2025 | FY2024 | Change | Source |
|---|---|---|---|---|
| Operating income | -$178.7 million | -$142.3 million | 10-K 2026-03-16 · proof | |
| Net income | -$162.5 million | -$129.5 million | 10-K 2026-03-16 · proof | |
| Cash from operating activities | -$146.7 million | -$104.4 million | 10-K 2026-03-16 · proof | |
| Total assets | $533.4 million | $451 million | +18.3% | 10-K 2026-03-16 · proof |
| Total liabilities | $54.9 million | $42 million | +30.6% | 10-K 2026-03-16 · proof |
| Cash and cash equivalents | $48.3 million | $139.5 million | -65.4% | 10-K 2026-03-16 · proof |
- What was Olema Pharmaceuticals, Inc. (OLMA)'s operating income in fiscal 2025?
- Olema Pharmaceuticals, Inc. (OLMA) reported operating income of -$178.7 million for fiscal 2025 (the year ended Dec 31, 2025), against -$142.3 million the year before. Source: the 10-K filed with the SEC on Mar 16, 2026. SEC
- What was Olema Pharmaceuticals, Inc. (OLMA)'s net income in fiscal 2025?
- Olema Pharmaceuticals, Inc. (OLMA) reported net income of -$162.5 million for fiscal 2025 (the year ended Dec 31, 2025), against -$129.5 million the year before. Source: the 10-K filed with the SEC on Mar 16, 2026. SEC
- What was Olema Pharmaceuticals, Inc. (OLMA)'s cash from operating activities in fiscal 2025?
- Olema Pharmaceuticals, Inc. (OLMA) reported cash from operating activities of -$146.7 million for fiscal 2025 (the year ended Dec 31, 2025), against -$104.4 million the year before. Source: the 10-K filed with the SEC on Mar 16, 2026. SEC
- What are Olema Pharmaceuticals, Inc. (OLMA)'s total assets?
- As of Dec 31, 2025, Olema Pharmaceuticals, Inc. (OLMA) reported total assets of $533.4 million, against $451 million a year earlier (+18.3%). Source: the 10-K filed with the SEC on Mar 16, 2026. SEC
- What are Olema Pharmaceuticals, Inc. (OLMA)'s total liabilities?
- As of Dec 31, 2025, Olema Pharmaceuticals, Inc. (OLMA) reported total liabilities of $54.9 million, against $42 million a year earlier (+30.6%). Source: the 10-K filed with the SEC on Mar 16, 2026. SEC
- What are Olema Pharmaceuticals, Inc. (OLMA)'s cash and cash equivalents?
- As of Dec 31, 2025, Olema Pharmaceuticals, Inc. (OLMA) reported cash and cash equivalents of $48.3 million, against $139.5 million a year earlier (-65.4%). Source: the 10-K filed with the SEC on Mar 16, 2026. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=ticker:OLMA&period_type=annual&limit=5"Information only, not investment advice.